AI Verdict
EVGN has stronger fundamentals based on our AI analysis.
EVH vs EVGN Fundamental Comparison
| Metric | EVH | EVGN |
|---|---|---|
| Revenue | $1.9B | N/A |
| Net Income | $-534.5M | N/A |
| Net Margin | -28.5% | N/A |
| ROE | -128.7% | N/A |
| ROA | -28.1% | N/A |
| Current Ratio | 1.31x | N/A |
| Debt/Equity | 2.34x | N/A |
| EPS | $-5.07 | N/A |
Green = Better metric | Red = Weaker metric
You Might Also Compare
EVH vs EVGN: Frequently Asked Questions
Is EVH or EVGN a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), EVGN has stronger fundamentals. EVH is rated STRONG SELL (92% confidence) while EVGN is rated SELL (85% confidence). This is not investment advice.
How does EVH compare to EVGN fundamentally?
Evolent Health, Inc. has ROE of -128.7% vs Evogene Ltd.'s N/A. Net margins are -28.5% vs N/A respectively.
Which stock pays higher dividends, EVH or EVGN?
EVH has a dividend yield of N/A or no dividend while EVGN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in EVH or EVGN for long term?
For long-term investing, consider that EVH has STRONG SELL rating with 92% confidence, while EVGN has SELL rating with 85% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about EVH vs EVGN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For EVH vs EVGN, the AI consensus favors EVGN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.